Your browser doesn't support javascript.
loading
An update on the central nervous system manifestations of tuberous sclerosis complex.
Cotter, Jennifer A.
Afiliación
  • Cotter JA; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USA. jcotter@chla.usc.edu.
Acta Neuropathol ; 139(4): 613-624, 2020 04.
Article en En | MEDLINE | ID: mdl-30976976
ABSTRACT
The autosomal dominant disorder tuberous sclerosis complex (TSC) is characterized by an array of manifestations both within and outside of the central nervous system (CNS), including hamartomas and other malformations. TSC is caused by mutations in the TSC1 or TSC2 gene resulting in activation of the mechanistic target of rapamycin (mTOR) signaling pathway. Study of TSC has shed light on the critical role of the mTOR pathway in neurodevelopment. This update reviews the genetic basis of TSC, its cardinal phenotypic CNS features, and recent developments in the field of TSC and other mTOR-altered disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerosis Tuberosa / Enfermedades del Sistema Nervioso Central Límite: Humans Idioma: En Revista: Acta Neuropathol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esclerosis Tuberosa / Enfermedades del Sistema Nervioso Central Límite: Humans Idioma: En Revista: Acta Neuropathol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos